+44 330 818 7254In hospitals and other health care facilities, antiseptics and disinfectants are widely utilized for a range of topical and hard-surface applications. They help prevent nosocomial infections in particular and are a crucial component of infection control procedures. Public usage of antiseptics and disinfectants has expanded as a result of growing worries about the risk of microbial contamination and infections in the food and general consumer sectors. These products include a wide range of active chemical substances (sometimes known as "biocides"), many of which have been used for antisepsis, disinfection, and preservation for hundreds of years. Despite this, less is known about these active drugs' modes of action than is the case with antibiotics. Antibiotics typically target particular intracellular targets, but biocides may target several intracellular targets. In general, biocides have a wider spectrum of action than antibiotics. Some have speculated that the increasing use of antiseptic and disinfection goods may be contributing to the rise of microbial resistance, particularly antibiotic cross-resistance. This review examines the current understanding of the processes behind microbial resistance to antiseptics and disinfectants, as well as their mode of action, and makes every effort to link this information to the clinical setting.
Share this article